Quiscent trophoblastic disease

Česká verzia

Authors: F. Hron; V. Hejda; J. Feyereisl; P. Šafář; H. Sochová
Authors place of work: Ústav pro péči o matku a dítě, Praha, ředitel doc. MUDr. J. Feyereisl, CSc. ; Centrum pro trofoblastickou nemoc v ČR, Praha
Published in the journal: Ceska Gynekol 2011; 76(6): 443-446
Category: Original Article

Summary

Type of study:
Case report.

Setting:
Center for trophoblastic disease in Czech Republic, Institute for care of mother and child, 3^rdFaculty of Medicine of Charles University Prague.

Methods:
The autors present a case of quiscent trophoblastic disease diagnosed at 27 years old primipara, secundigravida after previous molar pregnancy. The patient had low levels of serum hCG present for more than 18 months after the termination of pregnancy. After this period there was a malignant transformation associated with rapid elevation of hCG levels with need for chemotherapy which was succesfully completed.

Conclusion:
Quiscent (dormant, noninvasive) trophoblastic disease is a recently described unit defined by low levels of hCG present in patients serum and urine samples without any evidence of trophoblastic tumour or other source of hCG production. Quiscent trophoblastic disease is associated with high risk of malignant transformation.

Key words:
quiscent, trophoblastic, noninvasive, persistent, hCG.

Zdroje

1. Cole, LA., Khanlian, SA. Inappropriate management of women with persistent low hCG results. J Reprod Med, 2004, 49, p. 423‑432.

2. Cole, LA., Shahabi, S., Oz, UA., et al. Hyperglycosylated hCG (invasive trophoblastic antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem, 1999, 45, p. 2109-2119.

3. Cole, LA., Kohorn, E., Harriet, O., Smith, MD. Gestational Trophoblastic Disease: Management of cases with persistent low human chorionic gonadotropin results. Obstet Gynecol Clin N Am, 2005, 32, p. 615-626.

4. Cole, LA., Miller, CY. Hyperglycosylated hCG in the management of quiscent and chemorefractory gestational trophoblastic disease. Gynecol Oncol, 2010, 116(1), p. 3-9.

5. Hancock, BW., Tidy, JA. Clinical management of persistent low level hCG elevation. Trophobl Dis Upd, 2004, 4, p. 5-6.

6. Khanlian, SA., Smith, HO., Cole, LA. Persistent low levels of hCG: a premalignant gestational trophoblastic disease. Am J Obstet Gynecol, 2003, 188, p. 1254-1259.

7. Kohorn, EI. Persistent low-level „real“ human chorionic gonadotropin: a clinical challenge and a therapeutic dilema. Gynecol Oncol, 2002, 85, p. 315-320.

8. Kovaleskaya, G., Genbacev, O., Fisher, SJ., et al. Trophoblast origin of hCG isoforms, cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol Cell Endocrinol, 2002, 194, p. 147-155.

9. Zavadil, M. Trophoblastic disease. Praha: Acta Univ Carol Med, 1973, 19, 107 s.

10. Zavadil, M., Feyereisl, J., Krofta, L., et al. Persistent trophoblastic disease in Trophoblastic Disease Center in the Czech Republic in 1955-2007. Ces Gynek, 2008, 73(2), p. 73-79.